|
000
| 01791nam 2200349zi 4500 |
|---|
| 001 | 9.923931 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20230615150548 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 230615e202306##onc ob f|0| 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aXC80-1/1-441-14E-PDF |
|---|
| 110 | 1 |aCanada. |bParliament. |bHouse of Commons. |bStanding Committee on Industry and Technology, |eauthor, |eissuing body. |
|---|
| 245 | 10|aDomestic manufacturing capacity for a COVID-19 vaccine : |bprevention is better than cure / |cJoël Lightbound, chair. |
|---|
| 264 | 1|a[Ottawa] : |bHouse of Commons, Canada = Chambre des communes, Canada, |cJune 2023. |
|---|
| 300 | |a1 online resource (ix, 67 pages). |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 490 | 1 |aReport of the Standing Committee on Industry and Technology ; |v14th report, 44th Parliament, 1st session |
|---|
| 500 | |aIssued also in French under title: Capacité nationale de fabrication d'un vaccin contre la COVID-19 : mieux vaut prévenir que guérir. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aCOVID-19 (Disease)|xVaccination|zCanada. |
|---|
| 650 | 0|aVaccines industry|zCanada. |
|---|
| 700 | 1 |aLightbound, Joël. |
|---|
| 775 | 08|tCapacité nationale de fabrication d'un vaccin contre la COVID-19 : |w(CaOODSP)9.923934 |
|---|
| 830 | #0|aReport of the Standing Committee on Industry and Technology ;|v14th report, 44th Parliament, 1st session.|w(CaOODSP)9.908928 |
|---|
| 856 | 40|qPDF|s3.59 MB|uhttps://publications.gc.ca/collections/collection_2023/parl/xc80-1/XC80-1-1-441-14-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.ourcommons.ca/DocumentViewer/en/44-1/INDU/report-14 |
|---|